Full-Time

Senior Manager

Facilities & Lab Operations

Posted on 10/2/2024

Editas Medicine

Editas Medicine

201-500 employees

Develops gene editing treatments using CRISPR

Biotechnology

Senior

Cambridge, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s or Master’s degree in biology or a related field, and 8+ years of relevant experience working in facility and lab operations in a biotech company
  • DOT, IATA/DG Certified
  • Experience with procurement of lab common supplies, lab inventory management system, and working with external vendors
  • Expertise in contract/quotation negotiations, shipping/receiving is required
  • Knowledge of lab safety and OSHA regulations and safety training is required.
  • Experience with permitting, training, and reporting requirements as set forth by local, state, and federal regulations is preferred
  • Strong organizational, communication and interpersonal skills are required
  • Experience of optimizing and centralizing processes across groups is preferred
  • Experience with 5'S' or Lean principles is preferred
  • Experience with cell culture, protein expression and purification are a plus
Responsibilities
  • Oversee any construction, building repair, and maintenance programs.
  • Manage and oversee shipping for domestic and international shipments of materials, including the preparation of material for shipment and receiving from external vendors.
  • Anticipate, troubleshoot, and resolve problems associated with work within the facility, including occasional off-hours responses to emergencies.
  • Establish procedures; create and manage related documentation, and organizational processes such as annual laboratory cleanouts, de-frosting of freezers, HVAC maintenance, cold room maintenance, freezer/refrigerator inventory, and consumables inventory.
  • Manage cryogenics and compressed gases, including but not limited to placing requests with external vendor, monitoring, and swapping out cylinders and dewars, as needed.
  • Collaborate regularly with scientists to identify and address any workflow bottlenecks, inefficiencies, opportunities for process improvement, and logistical or administrative issues in the lab.
  • Support lab safety and regulatory compliance, including tracking biologics, chemicals, and hazardous materials, and enforcing PPE Policy and lab safety rules.
  • Handle and track biological waste and hazardous waste.
  • Manage laboratory space to maximize effective square footage, factoring equipment utilization, workflow, and assigned bench allocations.
  • Assist and support CapEx process, from conducting equipment specification assessments and space planning.
  • Collaborate with internal partners including HR, Legal, Procurement, IT, etc.
  • Contribute to the management of the Lab and Facilities Operations budget.
  • Oversee the general lab and facility organization and cleanliness.
  • Assist and support the permitting process.
  • In partnership with EHS, perform routine lab safety inspections and walkthroughs, and participate in monthly safety committee meetings.
  • Devise and implement Facility related SOP’s and Policies, such as Shipping SOP, Parking Policy, etc.

Editas Medicine focuses on gene editing using CRISPR technology, which allows for precise modifications to DNA in cells. This technique has the potential to correct genetic defects that lead to various diseases. The company is engaged in the entire process of drug development, from discovering new treatments to manufacturing and bringing them to market. Editas Medicine aims to create effective and lasting therapies that can enhance the quality of life for patients suffering from serious health conditions. Unlike many competitors, Editas Medicine has a diverse pipeline of experimental medicines and actively shares clinical data to engage with the medical community. Their goal is to provide transformative treatments for patients worldwide.

Company Stage

IPO

Total Funding

$321M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

2%

1 year growth

22%

2 year growth

27%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Genevant Sciences could enhance targeted delivery systems for gene therapies.
  • $50 million financing with DRI Healthcare Trust supports pipeline advancement and in-vivo programs.
  • Promising EDIT-101 trial results highlight potential to address genetic blindness.

What critics are saying

  • 65% workforce reduction may lead to operational challenges and development delays.
  • Pivot to in-vivo gene editing increases dependency on new research direction's success.
  • Reliance on external partnerships like Genevant Sciences may pose collaboration risks.

What makes Editas Medicine unique

  • Editas Medicine leverages CRISPR technology for precise gene editing therapeutics.
  • The company focuses on in-vivo gene editing, targeting stem cells and the liver.
  • Editas has substantial patent filings and access to foundational genome editing technologies.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE